Y-mAbs Therapeutics, Inc. (YMAB)

Quick facts

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Y-mAbs Therapeutics, Inc. portfolio CI brief
• Y-mAbs Therapeutics, Inc. pipeline updates RSS